Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Stoeltzing

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Molecular Cancer Therapeutics|September 3, 2011
Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancerJohannes Taeger, Christian Moser, Claus Hellerbrand, et al.
Molecular Cancer Therapeutics|November 13, 2008
Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytesSven A Lang, Philipp Schachtschneider, Christian Moser, et al.
Oncology (Williston Park, N.Y.)|July 10, 2002
Synopsis of angiogenesis inhibitors in oncologyLee M Ellis, Wenbiao Liu, Fan Fan, et al.
Molecular Cancer Therapeutics|November 21, 2007
Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivoChristian Moser, Sven A Lang, Silvia Kainz, et al.
Journal of the National Cancer Institute|June 17, 2004
Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturationOliver Stoeltzing, Marya F McCarty, Jane S Wey, et al.
The American Journal of Pathology|August 26, 2003
Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancerOliver Stoeltzing, Wenbiao Liu, Niels Reinmuth, et al.
Cancer|August 12, 2003
Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinomaAlexander A Parikh, Wen Biao Liu, Fan Fan, et al.
Surgery|December 18, 2009
Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental modelsChristina Hackl, Akira Mori, Christian Moser, et al.
Cancer Letters|October 24, 2007
Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) systemOliver Stoeltzing, Wenbiao Liu, Fan Fan, et al.
International Journal of Oncology|October 24, 2014
The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®)Andreas K A Gaumann, Hannes C A Drexler, Sven A Lang, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|September 3, 2011
Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancerJohannes Taeger, Christian Moser, Claus Hellerbrand, et al.
Molecular Cancer Therapeutics|November 13, 2008
Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytesSven A Lang, Philipp Schachtschneider, Christian Moser, et al.
Oncology (Williston Park, N.Y.)|July 10, 2002
Synopsis of angiogenesis inhibitors in oncologyLee M Ellis, Wenbiao Liu, Fan Fan, et al.
Molecular Cancer Therapeutics|November 21, 2007
Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivoChristian Moser, Sven A Lang, Silvia Kainz, et al.
Journal of the National Cancer Institute|June 17, 2004
Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturationOliver Stoeltzing, Marya F McCarty, Jane S Wey, et al.
The American Journal of Pathology|August 26, 2003
Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancerOliver Stoeltzing, Wenbiao Liu, Niels Reinmuth, et al.
Cancer|August 12, 2003
Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinomaAlexander A Parikh, Wen Biao Liu, Fan Fan, et al.
Surgery|December 18, 2009
Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental modelsChristina Hackl, Akira Mori, Christian Moser, et al.
Cancer Letters|October 24, 2007
Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) systemOliver Stoeltzing, Wenbiao Liu, Fan Fan, et al.
International Journal of Oncology|October 24, 2014
The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®)Andreas K A Gaumann, Hannes C A Drexler, Sven A Lang, et al.
Pageof 6